Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2018
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [<sup>18</sup>F] fluorodeoxyglucose and [<sup>18</sup>F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging
Gurdip K Azad, Benjamin P Taylor, Adrian Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2017
<sup>18</sup>F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients
Jim O'Doherty, Maite Jauregui-Osoro, Teresa Brothwood, et al.
Radiology
|
April 22, 2015
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis
Gary J R Cook, Mary E O'Brien, Muhammad Siddique, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 29, 2019
Exploratory radiomic features from integrated <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer
Serena Baiocco, Bert-Ram Sah, Andrew Mallia, et al.
Radiology
|
May 9, 2017
Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features
Sofia Gourtsoyianni, Georgia Doumou, Davide Prezzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 4, 2018
Imaging α<sub>v</sub>β<sub>3</sub> integrin expression in skeletal metastases with <sup>99m</sup>Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment
Gary J R Cook, Gurdip K Azad, Benjamin P Taylor, et al.
Nuclear Medicine Communications
|
July 30, 2011
Validation of image-derived arterial input functions at the femoral artery using 18F-fluoride positron emission tomography
Tanuj Puri, Glen M Blake, Michelle L Frost, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2021
Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma
Olwen Westerland, Ashik Amlani, Christian Kelly-Morland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 24, 2019
Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer
Yan Xing, Gitasha Chand, Changchun Liu, et al.
Nuclear Medicine Communications
|
March 24, 2012
Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT
Tanuj Puri, Glen M Blake, Michelle L Frost, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2018
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [<sup>18</sup>F] fluorodeoxyglucose and [<sup>18</sup>F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging
Gurdip K Azad, Benjamin P Taylor, Adrian Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2017
<sup>18</sup>F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients
Jim O'Doherty, Maite Jauregui-Osoro, Teresa Brothwood, et al.
Radiology
|
April 22, 2015
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis
Gary J R Cook, Mary E O'Brien, Muhammad Siddique, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 29, 2019
Exploratory radiomic features from integrated <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer
Serena Baiocco, Bert-Ram Sah, Andrew Mallia, et al.
Radiology
|
May 9, 2017
Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features
Sofia Gourtsoyianni, Georgia Doumou, Davide Prezzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 4, 2018
Imaging α<sub>v</sub>β<sub>3</sub> integrin expression in skeletal metastases with <sup>99m</sup>Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment
Gary J R Cook, Gurdip K Azad, Benjamin P Taylor, et al.
Nuclear Medicine Communications
|
July 30, 2011
Validation of image-derived arterial input functions at the femoral artery using 18F-fluoride positron emission tomography
Tanuj Puri, Glen M Blake, Michelle L Frost, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2021
Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma
Olwen Westerland, Ashik Amlani, Christian Kelly-Morland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 24, 2019
Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer
Yan Xing, Gitasha Chand, Changchun Liu, et al.
Nuclear Medicine Communications
|
March 24, 2012
Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT
Tanuj Puri, Glen M Blake, Michelle L Frost, et al.
Page
of 13